PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
PR: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project
PR: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
PR: Heidelberg Pharma Receives Milestone Payment from Partner Telix
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019
PR: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019
PR: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update
PR: Heidelberg Pharma Receives Milestone Payment From Partner Link Health
